These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38987218)

  • 1. Human platelet lysate supports SH-SY5Y neuroblastoma cell proliferation and differentiation into a dopaminergic-like neuronal phenotype under xenogeneic-free culture conditions.
    Ribeiro M; Campos J; Pinho TS; Sampaio-Marques B; Barata-Antunes S; Cibrão JR; Araújo R; Duarte-Silva S; Moreira E; Sousa RA; Costa PM; Salgado AJ
    Biotechnol J; 2024 Jul; 19(7):e2400068. PubMed ID: 38987218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
    Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
    Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
    Lim J; Choi HS; Choi HJ
    J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells.
    Ducray AD; Wiedmer L; Herren F; Widmer HR; Mevissen M
    CNS Neurol Disord Drug Targets; 2020; 19(8):618-629. PubMed ID: 32640966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
    Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
    Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
    Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
    Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
    Xie HR; Hu LS; Li GY
    Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
    Kovalevich J; Santerre M; Langford D
    Methods Mol Biol; 2021; 2311():9-23. PubMed ID: 34033074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica nanoparticle-exposure during neuronal differentiation modulates dopaminergic and cholinergic phenotypes in SH-SY5Y cells.
    Wiedmer L; Ducray AD; Frenz M; Stoffel MH; Widmer HR; Mevissen M
    J Nanobiotechnology; 2019 Apr; 17(1):46. PubMed ID: 30935413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells.
    Palombella S; Guiotto M; Higgins GC; Applegate LL; Raffoul W; Cherubino M; Hart A; Riehle MO; di Summa PG
    Stem Cell Res Ther; 2020 Oct; 11(1):432. PubMed ID: 33023632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.
    Kunzler A; Zeidán-Chuliá F; Gasparotto J; Girardi CS; Klafke K; Petiz LL; Bortolin RC; Rostirolla DC; Zanotto-Filho A; de Bittencourt Pasquali MA; Dickson P; Dunkley P; Moreira JCF; Gelain DP
    Mol Neurobiol; 2017 Nov; 54(9):6903-6916. PubMed ID: 27771902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.
    Coccini T; Vecchio S; Crevani M; De Simone U
    Neurotox Res; 2019 Jan; 35(1):49-62. PubMed ID: 29934755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol.
    Teppola H; Sarkanen JR; Jalonen TO; Linne ML
    Neurochem Res; 2016 Apr; 41(4):731-47. PubMed ID: 26518675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-virally-inactivated (Intercept-solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells.
    Barro L; Su YT; Nebie O; Wu YW; Huang YH; Koh MB; Knutson F; Burnouf T
    Transfusion; 2019 Jun; 59(6):2061-2073. PubMed ID: 30912158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
    Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
    Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cell culture model for investigation of synapse influenceability: epigenetics, expression and function of gene targets important for synapse formation and preservation in SH-SY5Y neuroblastoma cells differentiated by retinoic acid.
    Jahn K; Wieltsch C; Blumer N; Mehlich M; Pathak H; Khan AQ; Hildebrandt H; Frieling H
    J Neural Transm (Vienna); 2017 Nov; 124(11):1341-1367. PubMed ID: 28887651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.
    Saury C; Lardenois A; Schleder C; Leroux I; Lieubeau B; David L; Charrier M; Guével L; Viau S; Delorme B; Rouger K
    Stem Cell Res Ther; 2018 May; 9(1):128. PubMed ID: 29720259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.
    Appukuttan TA; Ali N; Varghese M; Singh A; Tripathy D; Padmakumar M; Gangopadhyay PK; Mohanakumar KP
    J Neurosci Res; 2013 Jul; 91(7):963-70. PubMed ID: 23653325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
    Jantas D; Roman A; Kuśmierczyk J; Lorenc-Koci E; Konieczny J; Lenda T; Lasoń W
    Neurotox Res; 2013 Jul; 24(1):41-54. PubMed ID: 23307753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing SH-SY5Y cell culture: exploring the beneficial effects of an alternative media supplement on cell proliferation and viability.
    Kaya ZB; Santiago-Padilla V; Lim M; Boschen SL; Atilla P; McLean PJ
    Sci Rep; 2024 Feb; 14(1):4775. PubMed ID: 38413790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.